Navigation Links
Drug companies in India keen on developing bird flu drug

The government is likely to invoke the compulsory licensing (CL) provision in the Patents Act that would enable domestic drug //firms to produce and stockpile Swiss drug maker Roche’s patented drug Tamiflu, useful in combating the global threat against the most dreaded avian flu virus.

Section 92 empowers the government to issue CL without receipt of an application from the industry. Furthermore, the issue of such license is independent of third party consent. The following proposal is expected to help cope up with a public health emergency that might arise in case the pandemic hits India. Once compulsory licensing has been issued, manufacture of the drug can be initiated, to ensure both domestic and international supply.

The drug companies in India are more than willing to participate in the initiative. Ranbaxy Laboratories has already initiated talks with the Swiss pharma company regarding the issue. The company is also getting in touch with governments across the world, interested in sourcing the drug from it.

The situation would however require a critical analysis of patents issue across the world. It would be six months before the drug can actually be manufactured following regulatory approvals.

In response to the above situation, Roche has announced it would not welcome interventions by generic drug makers in Tamiflu market, the demand for which has increased manifold following reports that the pandemic has reached Europe and SE Asia.

Medindia on Bird Flu:

Avian influenza (AI) or Bird Flu is a disease of viral etiology that ranges from a mild or even asymptomatic infection to an acute, fatal disease of chickens, turkeys, guinea fowls, and other avian species, especially migratory waterfowl
'"/>




Page: 1

Related medicine news :

1. India to benefit from pharma companies move
2. Doctors not to accept gifts from drug companies
3. Pharmaceutical companies are targeting patients
4. Historic trial for tuberculosis launched together by leading drug companies
5. Pakistan drug companies seek trade ties with India
6. Depression Accompanies Heart Attacks in Younger Women
7. Cigarette companies adopt devious methods to ensure customer patronage
8. Is Diabetes the Leading Cause of Kidney Failure in India
9. AIDS Disaster in India is Imminent
10. Indian Prime Minister has successful Knee Replacement Surgery
11. International community warns India on HIV situation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2017)... ... April 29, 2017 , ... ... to the list of fine retailers selling biodegradable, hanging flushable wipes dispensers and/or ... large supermarket chain headquartered in San Antonio, Texas, operates more than 350 stores ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... (The National Campaign) announces its support for the Access to Contraception for ... Jeanne Shaheen (D-NH) and Rep. Jackie Speier (D-CA), will help to ensure that ...
(Date:4/28/2017)... Lake City, UT (PRWEB) , ... April 28, 2017 , ... ... exist in some of their formulas. This begins with the popular ClearLungs Extra Strength ... they will be changing the formula in the following ways:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Date aired: ... , “Computers are everywhere and they’re here to stay,” said Sharon Kleyne on ... and Your Health on Voice America sponsored by Nature’s Tears® EyeMist®. So she ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt University ... first patients in Nashville , Tennesse ... Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. ... to provide long-term reflux control by restoring normal function ... nearly 65 million people in the United ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
Breaking Medicine Technology: